Evogene Ltd.
- Biotech or pharma, animal health
- Biotech or pharma, therapeutic R&D
- Other R&D services
Evogene (Nasdaq: EVGN) is an AI-focused computational chemistry and biology company accelerating drug discovery and development.
We collaborate with biotech and pharma companies, combining capabilities to co-develop innovative drugs.
We address a critical bottleneck in small molecule drug development: the discovery and design of highly potent, multi-parameter, novel compounds.
Our solution enables companies to create breakthrough therapies while achieving strong and comprehensive intellectual property protection.
At the core of our approach is ChemPass-AI — a proprietary computational platform powered by our in-house generative AI technology. Purpose-built to navigate uncharted chemical space, ChemPass-AI delivers finely optimized molecules that meet complex product specifications with exceptional potency.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}